Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT04775693
Other study ID # R-911-16
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date May 12, 2017
Est. completion date December 2022

Study information

Verified date February 2021
Source Kessler Foundation
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this RCT is to explore the clinical, functional and neurophysiological effectiveness of RE-assisted (Robotic Exoskeleton) early intervention gait therapy in stroke patients during inpatient and outpatient stroke rehabilitation as compared to traditional gait training in three groups: 1) RE; 2) RE-Standard of Care (SOC) and 3) SOC. We will evaluate the short and long-term effects on functional mobility, clinical, neurophysiological, community participation and quality of life.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 96
Est. completion date December 2022
Est. primary completion date December 2021
Accepts healthy volunteers No
Gender All
Age group 21 Years to 80 Years
Eligibility Inclusion Criteria: - Stroke survivors < 4 weeks from most recent stroke. - Age: 21- 80 years - Unilateral hemiparesis - Medical clearance by a Kessler Institute for Rehabilitation physician. - Be able to physically fit into the exoskeleton device. - Be able to tolerate upright standing for 30 minutes. - Have joint range of motion within normal functional limits for ambulation. - Have sufficient strength to use the hemiwalker, bilateral canes or walker while wearing the RE. - Have stable blood pressure; no diagnosis of persistent orthostatic hypotension (blood pressure drop of more than 30 millimeters of Mercury in body weight support system). - Patient cognitive status and ability to communicate in English must be at a level consistent with that required to participate in standard motor rehabilitation, e.g. can follow directions as determined by a Kessler Institute for Rehabilitation physician or physical therapist. - No history of injury or pathology to the unaffected limb. Exclusion Criteria: - Unable to physically fit within the RE: Height below 60" or above 76" and weight above 220 lbs. - Joint contracture or spasticity of any limb that limits normal ROM during ambulation with assistive devices. - Any medical issue that precludes full weight bearing and ambulation (e.g. orthopedic injuries, pain, severe spasticity). - Skin issues that would prevent wearing the device. - Pressure sore stage 2 or higher located in an area that would negatively affect weight bearing, harness fit, or therapist assistance. - Pre-existing condition that caused exercise intolerance.(Documented uncontrolled hypertension, coronary artery disease, cardiac arrhythmia, or congestive heart failure) - Hospitalization for heart attack, heart surgery or acute heart failure within 3 months of enrollment in study. - Severe cognitive or psychiatric problems as well as incontinence might be contraindications to start training with a RE. - History of severe cardiac disease such as myocardial infarction, congestive heart failure. - Uncontrolled seizure disorder. - Uncontrolled spasticity that would interfere with walking in the RENeuromuscular or neurological pathologies (e.g., Parkinson's disease, spinal cord injury, or traumatic brain injury with evidence of motor weakness and multiple sclerosis) that will interfere with neuromuscular function, ambulation, or limit the range of motion of the lower limbs - Orthopedic pathologies or history that will interfere with ambulation or limit the range of motion of the lower limbs (e.g., knee replacement, fixed contractures, inflammation) - Pregnant as confirmed by pregnancy test.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
RE (Robotic Exoskeleton)
Participants will continue to receive their prescribed standard of care physical therapy/gait training. They will also utilize the robotic exoskeleton twice a week during their inpatient stay and 3 times a week for 5 weeks as an outpatient (for outpatient, only if in the RE group). The Robotic Exoskeleton is a device that will be strapped to the chest and legs and worn over the shoulders like a backpack that will assist in walking. It uses sensors and participant motion to move. A licensed physical therapist will be assisting participants as they use the device.
Other:
SOC (standard of care)
Traditional physical therapist driven gait training.

Locations

Country Name City State
United States Kessler Foundation West Orange New Jersey

Sponsors (1)

Lead Sponsor Collaborator
Kessler Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Functional Independence Measure (FIM) a conventional assessment measure of motor function 6 months
Primary TUG time up and go (TUG) test 6 months
Primary BBA Berg Balance Assessment (BBA) 6 months
Primary ROM range of motion (ROM)- conventional assessment performed by a physical therapist 6 months
Primary strength conventional assessment performed by a physical therapist 6 months
Primary temporal spatial parameters collected though motion capture camera system 6 months
Primary plantar loading use of shoe insoles to gather information about foot pressure 6 months
Primary electromyography (EMG) a measure of muscle activation (EMG signal) at different phases of gait cycle (swing versus double support). 6 months
Primary SIS stroke impact scale (SIS). questionnaire about quality of life post-stroke 6 months
Primary LIFE-H assessment of life habits (LIFE-H). questionnaire about quality of life post-stroke 6 months
Primary SSQoL stroke specific quality of life scale (SSQoL). questionnaire about quality of life post-stroke 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05378035 - DOAC in Chinese Patients With Atrial Fibrillation
Completed NCT03574038 - Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke N/A
Completed NCT03679637 - Tablet-based Aphasia Therapy in the Acute Phase After Stroke N/A
Completed NCT03633422 - Evaluation of Stroke Patient Screening
Completed NCT04088578 - VNS-supplemented Motor Retraining After Stroke N/A
Not yet recruiting NCT05534360 - Tenecteplase Treatment in Ischemic Stroke Registry
Withdrawn NCT04991038 - Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients N/A
Not yet recruiting NCT04105322 - Effects of Kinesio Taping on Balance and Functional Performance in Stroke Patients N/A
Withdrawn NCT05786170 - ERILs Und SNILs Unter SOC N/A
Recruiting NCT03132558 - Contrast Induced Acute Kidney in Patients With Acute Stroke N/A
Completed NCT02893631 - Assessment of Hemostasis Disorders in rtPA-treated Patients Requiring Endovascular Treatment for Ischemic Stroke
Active, not recruiting NCT02274727 - Biomarker Signature of Stroke Aetiology Study: The BIOSIGNAL-Study
Completed NCT02225730 - Imaging Collaterals in Acute Stroke (iCAS)
Terminated NCT01705353 - The Role of HMGB-1 in Chronic Stroke N/A
Active, not recruiting NCT01581502 - SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF) N/A
Completed NCT01182818 - Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease N/A
Completed NCT00761982 - Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment. Phase 1/Phase 2
Completed NCT00535197 - Autologous Bone Marrow Stem Cells in Ischemic Stroke. Phase 1/Phase 2
Terminated NCT00132509 - FRALYSE Trial: Comparison of the Classical Rt-PA Procedure With a Longer Procedure in Acute Ischemic Stroke Phase 2
Recruiting NCT05760326 - Diagnostic and Prognostic Role of Clot Analysis in Stroke Patients